APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases

A patient with the PSEN1 E280A mutation and homozygous for APOE3 Christchurch (APOE3Ch) displayed extreme resistance to Alzheimer’s disease (AD) cognitive decline and tauopathy, despite having a high amyloid burden. To further investigate the differences in biological processes attributed to APOE3Ch...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Paula Perez-Corredor, Timothy E. Vanderleest, Guido N. Vacano, Justin S. Sanchez, Nelson D. Villalba-Moreno, Claudia Marino, Susanne Krasemann, Miguel A. Mendivil-Perez, David Aguillón, Marlene Jiménez-Del-Río, Ana Baena, Diego Sepulveda-Falla, Francisco Lopera, Yakeel T. Quiroz, Joseph F. Arboleda-Velasquez, Randall C. Mazzarino
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-03-01
Serie:	Frontiers in Molecular Neuroscience
Soggetti:	Wnt signaling ApoE iPS cells CRISPR Alzheimer’s disease ApoE Christchurch
Accesso online:	https://www.frontiersin.org/articles/10.3389/fnmol.2024.1373568/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!